This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 834,513 Years Active: 2022
Title: Innovations of Mohammad Abdul Sattar in GSK3B Inhibitors
Introduction
Mohammad Abdul Sattar is an accomplished inventor based in Telangana, India. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target specific biological pathways. His work focuses on creating innovative solutions for cancer treatment.
Latest Patents
One of his notable patents is titled "Spirooxindole compounds as GSK3B inhibitors and process for preparation thereof." This invention provides a compound of general formulae I that is useful as GSK3β inhibitors, showcasing its anticancer potential. The process for preparing these spirooxindoles is also detailed in the patent, highlighting the innovative approach taken by Sattar.
Career Highlights
Throughout his career, Mohammad Abdul Sattar has demonstrated a commitment to advancing scientific knowledge and developing practical applications for his research. His patent portfolio reflects his dedication to finding effective treatments for complex diseases.
Collaborations
He has collaborated with talented individuals such as Togapur Pavan Kumar and Divya Duscharla, contributing to a dynamic research environment that fosters innovation and creativity.
Conclusion
Mohammad Abdul Sattar's work in developing GSK3B inhibitors represents a significant advancement in cancer research. His innovative approach and dedication to his field continue to inspire future developments in medicinal chemistry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile